Page last updated: 2024-09-05

lenalidomide and Carcinoma, Adenoid Cystic

lenalidomide has been researched along with Carcinoma, Adenoid Cystic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alese, OB; Bilen, MA; Carthon, BC; Chen, Z; El-Rayes, BF; Harris, WB; Harvey, RD; Hossain, MS; Khuri, FR; Lawson, DH; Lewis, C; Lonial, S; Owonikoko, TK; Ramalingam, SS; Shaib, W; Steuer, CE; Waller, EK; Wu, C; Zhang, C1

Trials

1 trial(s) available for lenalidomide and Carcinoma, Adenoid Cystic

ArticleYear
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
    British journal of cancer, 2020, Volume: 123, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cytokines; Everolimus; Female; Humans; Lenalidomide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms

2020